Johnson & Johnson and Bayer settle Xarelto lawsuits for $775 million

Johnson& Johnson and Bayer agreed Monday to pay $775 million to settle almost 25,000 lawsuits in connection to blood thinner Xarelto. Each company will pay 50 percent of the settlement, according to The New York Times. The payment ends both state and federal cases — the New Brunswick, New Jersey-based Johnson& Johnson (NYSE: JNJ) jointly markets Xarelto with Bayer, which is based in Germany. Patients sued both companies, which failed to issue warnings regarding possible fatal bleeding episodes…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news